Archive for the 'Cancer' Category
Aggressive Multi-Modality Treatments May Lead To Better Outcomes For Patients 75 Years And Older With Brain Tumors
A new study from University Hospitals Case Medical Center (UHCMC) finds that elderly patients - 75 years old and older - with malignant brain tumors are not treated as aggressively as patients between 65 and 75 years old. Furthermore, the researchers find that if patients over 75 years old are treated aggressively, such as with surgery and radiation, they have better survival rates. The findings appear in the Journal of Neurosurgery.Original post by Allergy News From Medical News Today
No commentsRetraining Immune Cells To Kill Tumors
Immune cells called macrophages can destroy tumor cells by producing inflammatory proteins that are toxic to the tumor. But the environment inside the tumor somehow halts this production and instead causes the cells to make proteins that promote tumor growth.The new study identifies a protein, called IKK(beta), that drives this pro-tumor switch. This protein normally stimulates protective inflammation.Original post by Allergy News From Medical News Today
No commentsDiagnosis At Earliest Stage For Majority Of Kidney Cancers
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.Christopher J. Kane, M.D.Original post by Allergy News From Medical News Today
No commentsLife Expectancy And Life Lost For Cancer Patients
How long can a cancer patient survive (life expectancy), and how many years of life lost or shortened for patients with different types of cancer are of paramount importance to the patients, their families, and health policy makers? The aim of this study was to estimate life expectancy and years of life lost (EYLL) after the diagnosis of cancer.Original post by Allergy News From Medical News Today
No commentsLife Expectancy And Life Lost For Cancer Patients
How long can a cancer patient survive (life expectancy), and how many years of life lost or shortened for patients with different types of cancer are of paramount importance to the patients, their families, and health policy makers? The aim of this study was to estimate life expectancy and years of life lost (EYLL) after the diagnosis of cancer.Original post by Allergy News From Medical News Today
No commentsPotential New Roles For NSAID Medications
Recently, researchers have begun looking to NSAIDs as having a potential role in the prevention of colorectal cancer, esophageal cancer and pancreatitis. Three studies presented at Digestive Disease Week® 2008 (DDW®) investigate the potentially beneficial role that NSAID medications can play in the treatment of GI-related cancer and in the prevention of surgery-related inflammation.Original post by Allergy News From Medical News Today
No commentsPancreatic Cancer Cells Killed By Traditional Herbal Medicine, Jefferson Researchers Report
An herb used in traditional medicine by many Middle Eastern countries may help in the fight against pancreatic cancer, one of the most difficult cancers to treat. Researchers at the Kimmel Cancer at Jefferson in Philadelphia have found that thymoquinone, an extract of nigella sativa seed oil, blocked pancreatic cancer cell growth and killed the cells by enhancing the process of programmed cell death.Original post by Allergy News From Medical News Today
No commentsGenome-Wide Study Rapidly Scans DNA For Clues, Narrows Search For New Melanoma Gene
It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Despite years of research and clinical development, melanoma incidences continue to rise around the world.Original post by Allergy News From Medical News Today
No commentsRising Incidence Of Cancer Promotes Uptake Of Biopsy Devices Across Europe
The dramatic increase in the rate of cancer, coupled with the need for early detection, is driving the worldwide demand for biopsy devices. In Europe, the market for biopsy devices is facing challenges such as fierce competition and lack of reimbursements. Despite the dominance of tier I participants, there is still a significant level of competition among smaller participants for market share. New analysis from Frost & Sullivan (Original post by Allergy News From Medical News Today
No commentsElectronic Data The Focus For Latest ICR Seminar, UK
The Institute of Clinical Research (ICR) and the British Association of Research Quality Assurance (BARQA) are teaming up next month for a joint seminar focusing on the move to electronic data management. The seminar, entitled E-Source - Friend or Foe? A CRA’s guide to overcoming the challenges of monitoring electronic data, will take place on Thursday 19th June at the ICR’s headquarters in Bourne End, Buckinghamshire.Original post by Allergy News From Medical News Today
No comments